Daniel, this is from ILA's latest presentation to high value investors in the US under Near Term Miles stones states Milestone Timeframe Advancement of Galidesivir opportunity May 2025 , Based on this I would realistically expect an Ann to the market about the status. I know today is only the 21st, but it states May 2025 not Q4 FY 2025.
ILA Price at posting:
20.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)